|
|
|
|
Currently, Xiao Ping Ye is Chairman & General Manager at Hangzhou Tigermed Consulting Co., Ltd. Dr. Ye is also on the board of Dian Diagnostics Group Co. Ltd., Coland Holdings Ltd., Shanghai Guochuang Pharmaceutical Co., Ltd. and HBM Holdings Ltd.
Dr. Ye previously was Chief Medical Officer of Roche (China) Co. Ltd.
He received a doctorate from the University of Oxford.
|
| Aktuelle Stellungen und Verantwortungsbereiche Xiao Ping Ye | |
|
|
|
|
| Name | Aktien | % | Unternehmenswert |
| HANGZHOU TIGERMED CONSULTING DOM SH | 132 929 656 | 63,9% | 3 284 927 085 USD |
 Hangzhou Tigermed Consulting Co.,Ltd (300347)
(Biotechnologie) | 44 309 885 | 8,18% | 1 094 975 687 USD |
|
| Xiao Ping Ye : Persönliches Netzwerk | |
|
|
© 2021 People and Ownership : 
|
|
|
| Xiao Ping Ye : Verbindungen | |
|
|
| Aktuelle Nachrichten zu Xiao Ping Ye | |
|
- Keine Nachrichten - |
|
Canada
Deutschland
España
France
Italia
United Kingdom
United States
